Koçaşlı Sema, Demircan Zehra
Yildirim Beyazit Universitesi Ankara, Turkey.
Afr J Tradit Complement Altern Med. 2017 Jan 13;14(2):325-333. doi: 10.21010/ajtcam.v14i2.34. eCollection 2017.
The aim of this study was to evaluate of the use of herbal products in patients in both pre- and post- surgery periods and during chemotherapy, and to determine the factors behind it.
This study was conducted as a descriptive study with 281 patients in 4 centers. The data of the study were collected by using a survey form prepared by the researcher, depending on literature and interview with the participants face-to-face.
While the average age of the patients involved in the study is 49.1±12.8, 51.6% of them were females, 34.6% graduate of elementary school, and 34.5% were housewives. While the prevelance of the use of herbal product prior to surgical treatment is 38.9%, it was observed that this rate increased to 54.1% during chemotherapy. It was observed that the most frequently used product was garlic prior to surgical treatment (19.2%), that it was urtica dioica (13.8%) during chemotherapy. Before the surgical treatment, 94.3% of the patients, and during chemotherapy treatment, 81.7% of the patients, stated that the use of herbal product had not been questioned by the physician or nurse.
Analysis of the results indicates that health professionals need to obtain information regarding the use of herbal products by cancer patients during both pre- and post- surgery periods, as well as during chemotherapy. Patients should be provided with information and guidance about the advantages and disadvantages of using herbal products.
本研究的目的是评估草药产品在患者手术前、后以及化疗期间的使用情况，并确定其背后的因素。
本研究作为一项描述性研究，在4个中心对281名患者进行。研究数据通过研究者根据文献并与参与者面对面访谈编制的调查问卷收集。
参与研究的患者平均年龄为49.1±12.8岁，其中51.6%为女性，34.6%为小学毕业，34.5%为家庭主妇。手术治疗前使用草药产品的比例为38.9%，而在化疗期间这一比例升至54.1%。观察到手术治疗前最常使用的产品是大蒜（19.2%），化疗期间是荨麻（13.8%）。手术治疗前，94.3%的患者，化疗期间，81.7%的患者表示医生或护士未对其使用草药产品提出质疑。
结果分析表明，医疗专业人员需要获取癌症患者在手术前、后以及化疗期间使用草药产品的相关信息。应向患者提供关于使用草药产品利弊的信息和指导。
